On the 30th of September in the framework of the round table “Interdisciplinary approach to the development of innovation and export capacity of the EAEU pharmaceutical industry” a discussion about GLP took place. All over the world GLP system is the basis of quality of laboratory studies. The level of implementation of this system in developed countries correlates with the export and innovation potential of the pharmaceutical industry. Drug manufacturers, laboratories (testing and bioanalytical), experts and regulators spoke about the stage of implementation and harmonization of the domestic GLP system and the prospects for its development in the EAEU. The full test is available in Russian.
October 1-3, 2020 hosted a regular Rus-LASA conference dedicated to application issues discussion of modern technologies of scientific research, education, regulatory and ethical issues in this area. Read more on the website Rus-LASA.
The innovative sphere, the main part of science and research works, nowadays is the fundamental factor of qualitative economic growth. At the same time, this sphere requires huge financial and material costs, as well as very high qualification of workers.
In the article “The cost of research work on pre-clinical studies”, published on the website of GMP news, Doctor of Medical Sciences, Professor Valery Makarov, General Director of St. Petersburg Institute of Pharmacy talked about the structure of preclinical study expenses and how the cost of preclinical studies is formed.
Рress release is available only in Russian https://gmpnews.ru/2020/07/pochemu-v-rossii-ne-rabotaet-sistema-pravil-nadlezhashhej-laboratornoj-praktiki/
Рress release is available only in Russian https://gmpnews.ru/2020/07/farmrynok-zhdet-edinogo-regulyatora-v-oblasti-glp-inspekcij/
Details in the article https://gmpnews.ru/2020/04/chto-meshaet-vnedreniyu-glp-v-rossii/ [full text is available in Russian]
Great news! 50 days’ free access to the article Therapeutic efficacy of arginine-rich exenatide on diabetic neuropathy in rats before January 29, 2020. No sign up, registration or fees are required.
Final version of article https://authors.elsevier.com/c/1aCra3G5rd5HX
The Editors of Peptides, Olson Prize Selection Committee, and Elsevier Inc., are proud to announce that Valery G. Makarov has been selected as the 2018 winner of the GAYLE A. OLSON & RICHARD D. OLSON PRIZE awarded to the senior author of the most meritorious original research article published during the previous year in Peptides. Congratulations Professor Makarov! The winning article “A new tridecapeptide with an octaarginine vector has analgesic therapeutic potential and prevents morphine-induced tolerance” authored by Vladimir A. Kashkin, Elena V. Shekunova, Michail I. Titov, Ivan I. Eliseev, Maxim A. Gureev, Yuri B. Porozov, Marina N. Makarova, Valery G. Makarov was published in Peptides Volume 99 (January 2018) and has been made freely accessible until May 2020.